Drug Shortage Report for MYLAN-NITRO SUBLINGUAL SPRAY
Report ID | 148028 |
Drug Identification Number | 02243588 |
Brand name | MYLAN-NITRO SUBLINGUAL SPRAY |
Common or Proper name | NITRO SUBLINGUAL SPRAY |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NITROGLYCERIN |
Strength(s) | 0.4MG |
Dosage form(s) | METERED-DOSE AEROSOL |
Route of administration | SUBLINGUAL SUBLINGUAL |
Packaging size | 1BT |
ATC code | C01DA |
ATC description | VASODILATORS USED IN CARDIAC DISEASES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-10-25 |
Estimated end date | 2021-11-09 |
Actual end date | 2021-11-15 |
Shortage status | Resolved |
Updated date | 2021-11-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-11-17 | French | Compare |
v3 | 2021-11-17 | English | Compare |
v2 | 2021-10-26 | French | Compare |
v1 | 2021-10-26 | English | Compare |
Showing 1 to 4 of 4